When considering the clinical application of GLP-1RAs for ocular protection, a comparison with other modern antidiabetic agents, particularly SGLT2 inhibitors, is crucial
Only in the presence of active mitochondrial reductase enzymes does the reduction occur
**Please note that the information provided in this podcast is not intended to be a substitute for professional medical advice, diagnosis or treatment that can be provided by your own Medical Doctor
In February 2025, the FDA announced that the shortage of semaglutide injectable products (Ozempic, Wegovy) has been resolved, Dulaglutide (Trulicity) shortage resolved in June 2025
Diabetes Care (2004) 27:287480
Viscosity: Thicker, more viscous fluids require needles with a wider diameter (smaller gauge)